Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 3 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Breast 2 Tumor-Agnostic 1 Thoracic 1 Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 542 Pemetrexed 392 pembrolizumab 372 Cisplatin 356 Paclitaxel 285 Docetaxel 240 Gemcitabine 168 Nivolumab 158 Erlotinib Hydrochloride 147 Bevacizumab 114 atezolizumab 104 osimertinib 99 durvalumab 92 Etoposide 90 Gefitinib 68 130-nm albumin-bound paclitaxel 65 Cetuximab 64 Ipilimumab 60 Drug Therapy 51 Topotecan 48 Injections 44 Afatinib 41 tislelizumab 40 Cyclophosphamide 39 Albumin-Bound Paclitaxel 37 Vinorelbine 36 Crizotinib 34 cemiplimab 31 icotinib 26 Radiotherapy 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × vistusertib × Thoracic × Clear all

NCT03334617 2025-10-27

HUDSON

AstraZeneca

Phase 2 Active not recruiting

528 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡